Drug screens using the nematode Caenorhabditis elegans

Area of Science:

• * Genetics and Molecular Biology
• * Pharmacology and Drug Discovery

Background:

• * Caenorhabditis elegans (C. elegans) has a long history as a model organism for genetic analysis.
• * The advent of small molecule libraries transformed C. elegans into an accessible platform for academic drug discovery.

Purpose of the Study:

• * To review the history of large-scale drug screens using C. elegans.
• * To discuss current methods for identifying targets and pathways of novel drug hits.
• * To highlight C. elegans 's utility in discovering nematicides, anthelmintics, and tools for biological investigation, including neurodegeneration research.

Main Methods:

• * Review of historical large-scale drug screens in C. elegans.
• * Discussion of target and pathway identification techniques for novel chemical entities.
• * Focus on chemical genetic approaches utilizing C. elegans.

Main Results:

• * C. elegans facilitates the discovery of novel candidate nematicides and anthelmintics.
• * Small molecule tools for biological investigation have been developed using C. elegans screens.
• * Screens have also contributed to research in areas like neurodegeneration.

Conclusions:

• * C. elegans is an unparalleled whole-animal model system for early-stage drug discovery.
• * The combination of C. elegans 's genetic power and diverse small molecule libraries is key.
• * Its tractability makes it ideal for chemical genetic research.